EV-D68/RSV repRNA vaccines

N/A

Report date: 2026/04/15 11:09:10

Base Information

Drug NameEV-D68/RSV repRNA vaccines

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPicornavirus infectionAcute Flaccid Myelitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHDT Bio

China Registration ClassN/A

Develop Information

Active CompaniesHDT Bio

Inactive CompaniesN/A

Active IndicationsPicornavirus infectionAcute Flaccid Myelitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A